High-Dose Melphalan and the Development of Hematopoietic Stem-Cell Transplantation: 25 Years Later | Journal of Clinical Oncology
BEAM Conditioning Regimen Has Higher Toxicity Compared With High-Dose Melphalan for Salvage Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma. | Semantic Scholar
Hematopoietic recovery after high-dose melphalan and PBPC rescue | Download Table
High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal disease - Kidney International
A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma - Biology of Blood and Marrow Transplantation
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma | NEJM
High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review | Bone Marrow Transplantation
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis | NEJM
Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic
A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001) | PLOS ONE
Olanzapine versus Fosaprepitant for Chemotherapy-Induced Nausea and Vomiting Prophylaxis in Patients Receiving Single-Day High-Dose Melphalan
Next-Generation Sequencing to Assess the Impact of Low Dose Melphalan on Residual Disease before High-Dose Melphalan and Stem Cell Transplant in Multiple Myeloma - ScienceDirect
Role of high-dose Melphalan & ASCT | Int'l Myeloma Fn
Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma | Haematologica
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis | NEJM
Frontiers | Altered T-Lymphocyte Biology Following High-Dose Melphalan and Autologous Stem Cell Transplantation With Implications for Adoptive T-Cell Therapy
Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma | Bone Marrow Transplantation
Impact of Dose-Adjusted Melphalan in Obese Patients Undergoing Autologous Stem Cell Transplantation - Biology of Blood and Marrow Transplantation
Comparison of 1-day vs 2-day dosing of high-dose melphalan followed by autologous hematopoietic cell transplantation in patients with multiple myeloma | Bone Marrow Transplantation
The role of high-dose melphalan and autologous stem cell transplant in the rapidly evolving era of modern multiple myeloma therapy. | Semantic Scholar
Complications of high-dose Melphalan. | Download Table
Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma - Clinical Lymphoma, Myeloma and Leukemia
Phagocyte function decreases after high-dose treatment with melphalan and autologous stem cell transplantation in patients with multiple myeloma - Experimental Hematology
High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial | Bone Marrow Transplantation
Studies Comparing High-Dose Melphalan and Autologous SCT with... | Download Table
